Our previous studies revealed that the levels of Ang-(1-7), the main effector of ACE2/Ang-(1-7)/MAS1 axis, were reduced in the plasma of sporadic AD patients as well as the brain tissues of AD animal models [6, 7]. Here, ACE2 is linked to Alzheimer disease.